Recent Finacing
Recent Raise
RubrYc Therapeutics uses proprietary machine-learning and computational biology with diverse chemical libraries to discover epitope-selective mono‑ and bispecific antibodies, building an antibody discovery platform and partnering for development and manufacturing.
